Update by IDA FoundationLeontien Ruttenberg MSc MBA

Our mission:

“To improve access to and deliver high-quality medicines and

medical supplies at the lowest possible price

to low and middle income countries.”

Introducing IDA Foundation

…a not-for-profit supplier of essential medicines and medical supplies since 1972

• Customers in 130+ countries• 40+ agents worldwide & 10 locations with stock• Head office in Amsterdam (110 employees)• Procurement office in Mumbai (65 employees)

IDA Foundation: global presence

Customers and partnersMULTILATERAL FUNDING

MULTILATERAL PROGRAM & FUNDING

The Global Fund to Fight Aids, Tuberculosis and Malaria

Drug-purchasing facility (providesfunding grants) Hosted by WHO

The World Bank

World Health Organisation

BILATERAL

NGO & PRIVATE FOUNDATIONS

PRESIDENT’S MALARIA INITIATIVE

(PMI)

President’s Emergency

Plan for AIDS Relief

(PEPFAR)

Clinton Health Access Initiative

(CHAI)

GLOBAL DRUG FACILITY (GDF)The Global Health Network

National Ministries of Health (MoH)

Local NGOs

Central Medical Stores

• Multi-channel approach• Procurement Services, wholesale & tender proposals

• Portfolio of > 3000 products• Stock keeping 750 products • Average stock value: € 12 million• Increased turnover over the years with customer ranging

from hospitals to large donors• Emergency response

• 4 Global PA contracts (GDF (2), CHAI, PPM)• 2 National PA contracts(Togo, Nigeria)

• 30 Audits

IDA Foundation : key facts 2014

Guaranteed quality for pharmaceuticals and medical supplies*

(*process may vary depending on risk class)

More than quality control ‘on paper’ verification audits, samples

Leading in quality innovation: role in MQAS, WHO working groups

Own product: registrations in destination country

Dedicated pharmacists in our QA / QC teams in NL, Mumbai, China

IDA Quality

Update on achievements 2014

Product range:• RMNCH: reviewed portfolio to include UN 13

commodities• NCD: reviewed portfolio, added 26 anti-cancer drugs to

be completed in Q1, 2015• HIV/AIDS ; increased focus – re-establish value added

Quality• Bioequivalence studies

Supply Chain Management• Custom – made kitting projects / more complex supply

chain solutions

Update on challenges 2014Product range:• Stock keeping, shelf-life requirements, lead time• Local manufacturing – price differences w/ Asian

generics• Registration

Lack of standardization in medical devices• No standard list• No standard quality guidelines

Quality• Bioequivalence studies• Harmonization QA guidelines• Focus on local manufacturers may jeopardize uniformity

(eg Universal) • Complying to different standards costs time/donor money

Any Questions / Feedback?

Contact: lruttenberg@idafoundation.org

www.idafoundation.org

Join us on:IDA.Foundation.Amsterdam

IDA_Foundation

Summary

• IDA continues to passionately serve unmet needs

• Not for profit, independant & transparant

• Looking forward to increased harmonization

• Partnership approach